한글목차

해양성 펩타이드의 시장 규모는 지속가능한 생리활성 화합물에 대한 수요 증가로 인해 크게 성장할 것으로 예상됩니다. 해양 생물에서 유래한 해양성 펩타이드는 그 건강상의 이점이 널리 알려져 있으며, 식품, 화장품, 의약품을 포함한 여러 산업에 적용되고 있습니다. 면역조절제, 항산화제, 항염증제로 사용되는 이 펩타이드는 전 세계 웰빙 운동에 필수적인 요소로 자리 잡고 있습니다.

해양성 펩타이드 시장은 크게 성장하여 2025년에는 3억 5,095만 달러, 2032년에는 5억 4,179만 달러의 시장 가치를 달성할 것으로 예상되며, 예측 기간 동안 CAGR은 6.40%로 안정적일 것으로 예상됩니다. 추출 기술의 혁신과 해양성 펩타이드의 건강상의 이점에 대한 인식의 증가가 이러한 성장을 촉진하는 주요 요인입니다. 또한, 건강보조식품 및 기능성 제품에 대한 선호도 증가도 시장 확대를 뒷받침하고 있습니다.

해양성 펩타이드는 자외선 차단, 안티에이징, 뛰어난 보습 효과로 인기를 끌고 있습니다. 비침습적 치료와 피부 필러에 적용되면서 해양성 펩타이드는 기존 미용 시술의 대안으로 선호되고 있습니다. 건강 증진을 위해 해양성 펩타이드가 풍부한 기능성 식품과 건강보조식품을 찾는 소비자들이 늘고 있습니다. 이러한 펩타이드가 건강보조식품에 함유되면서 그 인기가 높아지고 있습니다. 고품질 해양성 펩타이드의 추출 방법의 개선으로 생산의 비효율성이 감소하여 다양한 산업 분야에서 활용되고 있습니다.

세계의 해양성 펩타이드 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별, 최종 용도별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등의 정보를 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나·러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 세계의 해양성 펩타이드 시장 전망, 2019-2032년

• 세계의 해양성 펩타이드 시장 전망, 제품 유형별, 금액(10억 달러), 2019-2032년
• 세계의 해양성 펩타이드 시장 전망, 최종 용도별, 금액(10억 달러), 2019-2032년
• 세계의 해양성 펩타이드 시장 전망, 지역별, 금액(10억 달러), 2019-2032년

제4장 북미의 해양성 펩타이드 시장 전망, 2019-2032년

제5장 유럽의 해양성 펩타이드 시장 전망, 2019-2032년

제6장 아시아태평양의 해양성 펩타이드 시장 전망, 2019-2032년

제7장 라틴아메리카의 해양성 펩타이드 시장 전망, 2019-2032년

제8장 중동 및 아프리카의 해양성 펩타이드 시장 전망, 2019-2032년

제9장 경쟁 구도

• 제품 유형과 최종 용도별 히트맵
• 기업 시장 점유율 분석, 2025년
• 경쟁 대시보드
• 기업 개요
  • Amicogen Inc.
  • Cargill Inc.
  • China Peptides
  • Darling Ingredients
  • Gelita AG
  • Guangzhou Honsea Sunshine Bio Science & Technology
  • Lapi Gelatine
  • Nippi Collagen
  • Nitta Gelatin
  • PB Gelatins or PB Leiner
  • Rousselot(Peptan)
  • Trobas Gelatine B.V.

제10장 부록

영문목차

The marine peptide market is poised for substantial growth, driven by the increasing demand for sustainable, bioactive compounds. Marine peptides, derived from marine organisms, are widely recognized for their health benefits and applications across multiple industries, including food, cosmetics, and pharmaceuticals. These peptides, used as immune modulators, antioxidants, and anti-inflammatory agents, are becoming integral to the global wellness movement.

Market Insights

The marine peptide market is anticipated to grow significantly, achieving a market value of $350.95 million by 2025 and $541.79 million by 2032, with a steady CAGR of 6.40% during the forecast period. Innovations in extraction techniques and increasing awareness about the health advantages of marine peptides are key factors driving this growth. The growing preference for nutraceuticals and functional products also supports the market's expansion.

Market Growth Drivers

• 1. Increasing Adoption in the Cosmetics Sector: Marine peptides have become popular for their roles in UV protection, anti-aging, and superior moisturizing properties. Their application in non-invasive treatments and dermal fillers positions marine peptides as a preferred alternative to traditional cosmetic procedures.
• 2. Rising Demand for Nutraceuticals: Consumers are increasingly turning to functional foods and dietary supplements enriched with marine peptides for improved health and wellness. The integration of these peptides into nutraceutical products has boosted their popularity.
• 3. Advancements in Extraction Techniques: Enhanced methods for deriving high-quality marine peptides have reduced production inefficiencies, making them more accessible to a broad range of industries.

Business Opportunities

• 1. Nutraceutical Sector Expansion: The demand for marine peptides is rising as consumers seek products addressing age-related health concerns. Marine peptide-based supplements offering essential nutrients, such as calcium and proteins, are gaining traction.
• 2. Growing Applications in Agriculture: Marine peptides have demonstrated efficacy in improving crop performance and resilience during droughts, creating opportunities in the agricultural sector in regions like South Asia and Oceania.
• 3. Pharmaceutical Applications: Marine peptides are increasingly used in managing blood pressure and reducing cardiac risks, opening doors for further innovation in pharmaceutical formulations.

Regional Analysis

North America: North America leads the marine peptide market, driven by a robust demand for pharmaceutical and nutraceutical applications. A surge in R&D activities, coupled with collaborations between international and regional players, bolsters market growth in the region.

South Asia & Oceania: This region is witnessing significant growth due to rising awareness about health and beauty benefits associated with marine peptides. Demand in agriculture and animal nutrition further supports market expansion.

Europe: Europe remains a critical market due to high demand for sustainable and organic cosmetic and nutraceutical products.

Market Restraints

• 1. High Production Costs: Sophisticated extraction techniques and sustainable sourcing methods contribute to elevated production expenses, posing challenges to affordability and market scalability.
• 2. Allergies Related to Marine Sourcing: Concerns over allergies associated with seafood-derived products limit the consumer base for marine peptides, particularly for individuals with sensitivity to marine products.

Key Players

Prominent companies in the marine peptide market include:

• Amicogen Inc.
• Cargill Inc.
• China Peptides
• Darling Ingredients
• Gelita AG
• Guangzhou Honsea Sunshine Bio Science & Technology
• Lapi Gelatine
• Nippi Collagen
• Nitta Gelatin
• PB Gelatins or PB Leiner
• Rousselot (Peptan)
• Trobas Gelatine B.V.

These companies focus on developing innovative, high-quality marine peptide products and leveraging R&D investments to expand their market presence.

Recent Developments

• 1. New Product Launch: In January 2021, Rousselot introduced a premium marine peptide supplement, Peptan Marine, designed to enhance skincare and pharmaceutical products. This launch underscores the growing demand for sustainable and high-performance marine-derived ingredients.

Market Impact: This innovation is expected to strengthen Rousselot's position in the global market while reshaping consumer preferences for marine-sourced peptides.

Market Segmentation

By Product Type:

• Fish Peptides
• Shellfish Peptides
• Seaweed Peptides
• Sponge Peptides
• Squid Peptides
• Other Product Types

By End-use Applications:

• Food and Beverages
• Cosmetics
• Pharmaceuticals
• Nutraceuticals
• Animal Feed
• Biotechnology
• Other End Uses

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Marine Peptide Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2025
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Global Marine Peptide Market Outlook, 2019 - 2032

• 3.1. Global Marine Peptide Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
  • 3.1.1. Key Highlights
    • 3.1.1.1. Fish peptides
    • 3.1.1.2. Shellfish peptides
    • 3.1.1.3. Seaweed peptides
    • 3.1.1.4. Sponge peptides
    • 3.1.1.5. Squid peptides
    • 3.1.1.6. Others
• 3.2. Global Marine Peptide Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
  • 3.2.1. Key Highlights
    • 3.2.1.1. Food and Beverages
    • 3.2.1.2. Cosmetics
    • 3.2.1.3. Pharmaceuticals
    • 3.2.1.4. Nutraceuticals
    • 3.2.1.5. Animal Feed
    • 3.2.1.6. Biotechnology
    • 3.2.1.7. Others
• 3.3. Global Marine Peptide Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
  • 3.3.1. Key Highlights
    • 3.3.1.1. North America
    • 3.3.1.2. Europe
    • 3.3.1.3. Asia Pacific
    • 3.3.1.4. Latin America
    • 3.3.1.5. Middle East & Africa

4. North America Marine Peptide Market Outlook, 2019 - 2032

• 4.1. North America Marine Peptide Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
  • 4.1.1. Key Highlights
    • 4.1.1.1. Fish peptides
    • 4.1.1.2. Shellfish peptides
    • 4.1.1.3. Seaweed peptides
    • 4.1.1.4. Sponge peptides
    • 4.1.1.5. Squid peptides
    • 4.1.1.6. Others
• 4.2. North America Marine Peptide Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
  • 4.2.1. Key Highlights
    • 4.2.1.1. Food and Beverages
    • 4.2.1.2. Cosmetics
    • 4.2.1.3. Pharmaceuticals
    • 4.2.1.4. Nutraceuticals
    • 4.2.1.5. Animal Feed
    • 4.2.1.6. Biotechnology
    • 4.2.1.7. Others
  • 4.2.2. BPS Analysis/Market Attractiveness Analysis
• 4.3. North America Marine Peptide Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 4.3.1. Key Highlights
    • 4.3.1.1. Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 4.3.1.2. Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 4.3.1.3. Canada Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 4.3.1.4. Canada Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
  • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Marine Peptide Market Outlook, 2019 - 2032

• 5.1. Europe Marine Peptide Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
  • 5.1.1. Key Highlights
    • 5.1.1.1. Fish peptides
    • 5.1.1.2. Shellfish peptides
    • 5.1.1.3. Seaweed peptides
    • 5.1.1.4. Sponge peptides
    • 5.1.1.5. Squid peptides
    • 5.1.1.6. Others
• 5.2. Europe Marine Peptide Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
  • 5.2.1. Key Highlights
    • 5.2.1.1. Food and Beverages
    • 5.2.1.2. Cosmetics
    • 5.2.1.3. Pharmaceuticals
    • 5.2.1.4. Nutraceuticals
    • 5.2.1.5. Animal Feed
    • 5.2.1.6. Biotechnology
    • 5.2.1.7. Others
  • 5.2.2. BPS Analysis/Market Attractiveness Analysis
• 5.3. Europe Marine Peptide Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 5.3.1. Key Highlights
    • 5.3.1.1. Germany Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 5.3.1.2. Germany Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 5.3.1.3. U.K. Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 5.3.1.4. U.K. Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 5.3.1.5. France Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 5.3.1.6. France Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 5.3.1.7. Italy Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 5.3.1.8. Italy Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 5.3.1.9. Turkey Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 5.3.1.10. Turkey Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 5.3.1.11. Russia Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 5.3.1.12. Russia Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 5.3.1.13. Rest of Europe Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 5.3.1.14. Rest of Europe Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Marine Peptide Market Outlook, 2019 - 2032

• 6.1. Asia Pacific Marine Peptide Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
  • 6.1.1. Key Highlights
    • 6.1.1.1. Fish peptides
    • 6.1.1.2. Shellfish peptides
    • 6.1.1.3. Seaweed peptides
    • 6.1.1.4. Sponge peptides
    • 6.1.1.5. Squid peptides
    • 6.1.1.6. Others
• 6.2. Asia Pacific Marine Peptide Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
  • 6.2.1. Key Highlights
    • 6.2.1.1. Food and Beverages
    • 6.2.1.2. Cosmetics
    • 6.2.1.3. Pharmaceuticals
    • 6.2.1.4. Nutraceuticals
    • 6.2.1.5. Animal Feed
    • 6.2.1.6. Biotechnology
    • 6.2.1.7. Others
  • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
• 6.3. Asia Pacific Marine Peptide Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 6.3.1. Key Highlights
    • 6.3.1.1. China Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 6.3.1.2. China Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 6.3.1.3. Japan Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 6.3.1.4. Japan Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 6.3.1.5. South Korea Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 6.3.1.6. South Korea Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 6.3.1.7. India Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 6.3.1.8. India Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 6.3.1.9. Southeast Asia Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 6.3.1.10. Southeast Asia Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 6.3.1.11. Rest of Asia Pacific Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 6.3.1.12. Rest of Asia Pacific Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Marine Peptide Market Outlook, 2019 - 2032

• 7.1. Latin America Marine Peptide Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
  • 7.1.1. Key Highlights
    • 7.1.1.1. Fish peptides
    • 7.1.1.2. Shellfish peptides
    • 7.1.1.3. Seaweed peptides
    • 7.1.1.4. Sponge peptides
    • 7.1.1.5. Squid peptides
    • 7.1.1.6. Others
• 7.2. Latin America Marine Peptide Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
  • 7.2.1. Key Highlights
    • 7.2.1.1. Food and Beverages
    • 7.2.1.2. Cosmetics
    • 7.2.1.3. Pharmaceuticals
    • 7.2.1.4. Nutraceuticals
    • 7.2.1.5. Animal Feed
    • 7.2.1.6. Biotechnology
    • 7.2.1.7. Others
  • 7.2.2. BPS Analysis/Market Attractiveness Analysis
• 7.3. Latin America Marine Peptide Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 7.3.1. Key Highlights
    • 7.3.1.1. Brazil Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 7.3.1.2. Brazil Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 7.3.1.3. Mexico Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 7.3.1.4. Mexico Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 7.3.1.5. Argentina Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 7.3.1.6. Argentina Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 7.3.1.7. Rest of Latin America Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 7.3.1.8. Rest of Latin America Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Marine Peptide Market Outlook, 2019 - 2032

• 8.1. Middle East & Africa Marine Peptide Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
  • 8.1.1. Key Highlights
    • 8.1.1.1. Fish peptides
    • 8.1.1.2. Shellfish peptides
    • 8.1.1.3. Seaweed peptides
    • 8.1.1.4. Sponge peptides
    • 8.1.1.5. Squid peptides
    • 8.1.1.6. Others
• 8.2. Middle East & Africa Marine Peptide Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
  • 8.2.1. Key Highlights
    • 8.2.1.1. Food and Beverages
    • 8.2.1.2. Cosmetics
    • 8.2.1.3. Pharmaceuticals
    • 8.2.1.4. Nutraceuticals
    • 8.2.1.5. Animal Feed
    • 8.2.1.6. Biotechnology
    • 8.2.1.7. Others
  • 8.2.2. BPS Analysis/Market Attractiveness Analysis
• 8.3. Middle East & Africa Marine Peptide Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 8.3.1. Key Highlights
    • 8.3.1.1. GCC Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 8.3.1.2. GCC Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 8.3.1.3. South Africa Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 8.3.1.4. South Africa Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 8.3.1.5. Egypt Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 8.3.1.6. Egypt Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 8.3.1.7. Nigeria Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 8.3.1.8. Nigeria Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 8.3.1.9. Rest of Middle East & Africa Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
    • 8.3.1.10. Rest of Middle East & Africa Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. Product Type vs by End Use Application Heatmap
• 9.2. Company Market Share Analysis, 2025
• 9.3. Competitive Dashboard
• 9.4. Company Profiles
  • 9.4.1. Amicogen Inc.
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Product Portfolio
    • 9.4.1.3. Financial Overview
    • 9.4.1.4. Business Strategies and Development
  • 9.4.2. Cargill Inc.
    • 9.4.2.1. Company Overview
    • 9.4.2.2. Product Portfolio
    • 9.4.2.3. Financial Overview
    • 9.4.2.4. Business Strategies and Development
  • 9.4.3. China Peptides
    • 9.4.3.1. Company Overview
    • 9.4.3.2. Product Portfolio
    • 9.4.3.3. Financial Overview
    • 9.4.3.4. Business Strategies and Development
  • 9.4.4. Darling Ingredients
    • 9.4.4.1. Company Overview
    • 9.4.4.2. Product Portfolio
    • 9.4.4.3. Financial Overview
    • 9.4.4.4. Business Strategies and Development
  • 9.4.5. Gelita AG
    • 9.4.5.1. Company Overview
    • 9.4.5.2. Product Portfolio
    • 9.4.5.3. Financial Overview
    • 9.4.5.4. Business Strategies and Development
  • 9.4.6. Guangzhou Honsea Sunshine Bio Science & Technology
    • 9.4.6.1. Company Overview
    • 9.4.6.2. Product Portfolio
    • 9.4.6.3. Financial Overview
    • 9.4.6.4. Business Strategies and Development
  • 9.4.7. Lapi Gelatine
    • 9.4.7.1. Company Overview
    • 9.4.7.2. Product Portfolio
    • 9.4.7.3. Financial Overview
    • 9.4.7.4. Business Strategies and Development
  • 9.4.8. Nippi Collagen
    • 9.4.8.1. Company Overview
    • 9.4.8.2. Product Portfolio
    • 9.4.8.3. Financial Overview
    • 9.4.8.4. Business Strategies and Development
  • 9.4.9. Nitta Gelatin
    • 9.4.9.1. Company Overview
    • 9.4.9.2. Product Portfolio
    • 9.4.9.3. Financial Overview
    • 9.4.9.4. Business Strategies and Development
  • 9.4.10. PB Gelatins or PB Leiner
    • 9.4.10.1. Company Overview
    • 9.4.10.2. Product Portfolio
    • 9.4.10.3. Financial Overview
    • 9.4.10.4. Business Strategies and Development
  • 9.4.11. Rousselot (Peptan)
    • 9.4.11.1. Company Overview
    • 9.4.11.2. Product Portfolio
    • 9.4.11.3. Financial Overview
    • 9.4.11.4. Business Strategies and Development
  • 9.4.12. Trobas Gelatine B.V.
    • 9.4.12.1. Company Overview
    • 9.4.12.2. Product Portfolio
    • 9.4.12.3. Financial Overview
    • 9.4.12.4. Business Strategies and Development

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations